Showing 5,961 - 5,980 results of 25,756 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 0.83s Refine Results
  1. 5961
  2. 5962

    SARS-CoV-2 antibody responses are sustained and are predominantly focused on Spike. by Fiona Tea (2502700)

    Published 2021
    “…Convalescent patient sera from ADAPT (first and second waves) and LIFE (first wave) were examined for SARS-CoV-2 antibodies. Mean time and range of PCR positivity (red) and dates of first and last sample collection (blue) are shown. …”
  3. 5963
  4. 5964

    Consequences of global and local c-di-GMP changes on <i>V</i>. by Andrew A. Bridges (1587328)

    Published 2022
    “…<p><b><i>cholerae</i> gene expression patterns.</b> Bottom panel: mean global c-di-GMP reporter outputs for the indicated strains and conditions expressed as percentage differences relative to untreated wild-type <i>V</i>. …”
  5. 5965
  6. 5966

    SENP5 knockdown antagonizes the effect of TPEN on apoptosis and induced abnormal differentiation of hiPSCs. by Xiaoyu Zhang (62901)

    Published 2020
    “…TPEN (10 μM) significantly decreased hiPSC-CM viability, which was abrogated by siSENP5 (n = 6). …”
  7. 5967
  8. 5968
  9. 5969
  10. 5970

    Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes with Alirocumab: Post-Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial by Gregory G. Schwartz (20599125)

    Published 2025
    “…<a href="" target="_blank">OR for NOD for 25% and 50% lipoprotein(a) reductions were 1.12 (95% CI 1.01</a>-1.23) and 1.24 (1.02-1.52). …”
  11. 5971

    Removal of specific N-glycans can alter neutralization potency and completeness. by Sabrina Lusvarghi (2329267)

    Published 2023
    “…<p>(A) Structure of SARS-CoV-2 spike in the closed conformation complexed with Bebtelovimab (PDBID:7MMO, yellow), C135 (PDBID: 7K8Z, green) and S309 (red, PDBID: 6WPS). …”
  12. 5972
  13. 5973
  14. 5974
  15. 5975
  16. 5976
  17. 5977
  18. 5978
  19. 5979

    REG-O3 chimeric peptide combining growth hormone and somatostatin sequences improves joint function and prevents cartilage degradation in rat model of traumatic knee osteoarthritis by Rodrick Montjean (400649)

    Published 2020
    “…The effect of REG-O3, solubilized in a liposomal solution and injected at either 5, 25 or 50 μg/50 μL, was compared to liposomal (LIP), dexamethasone and hyaluronic acid (HA) solutions. …”
  20. 5980